January 18th, 2017

Discover our CEO Dr George Syrmalis at the Sky News studios discussing The iQ Group Global’s plans to commercialise the saliva glucose Biosensor

January 18th, 2017

The iQ Group Global CEO Dr George Syrmalis explains the value of cross-listing on Bloomberg, with early-stage Australian assets, are discounted by about

November 30th, 2016

Dr George Syrmalis, Founder & CEO of The IQ Group Global in CEO Magazine. An oncology drug that introduces a new therapeutic class

November 9th, 2016

There is a growing national consensus that as the mining boom fades and China’s growth slows, Australia’s future prosperity is linked to growth

August 24th, 2016

Unique and innovative pharmaceutical industry leader The iQ Group Global continues to gather momentum with two recent promotions within their executive team –

July 21st, 2016

iQ3Corp Ltd’s (ASX:IQ3) fully owned subsidiary, iQ Capital, has obtained a license to operate an investment banking business in New York, after registration